Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lim

Showing results (411-420 of 432) with videos related to

Pageof 44
Sort By:
Epigenetics|September 12, 2012
Measuring the methylome in clinical samples: improved processing of the Infinium Human Methylation450 BeadChip ArrayHong Pan, Li Chen, Shaillay Dogra, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
The Veterinary Record|January 8, 2008
Feed contaminated with classical swine fever vaccine virus (LOM strain) can induce antibodies to the virus in pigsB Kim, J-Y Song, D-S Tark, et al.
Ophthalmology|February 21, 2024
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Arshad M Khanani, Aachal Kotecha, Andrew Chang, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
Signal Transduction and Targeted Therapy|October 21, 2025
Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunctionMaximilian A McCann, Basma Baccouche, Yueru Li, et al.
Journal of Vitreoretinal Diseases|August 5, 2025
The Influence of Ultra-Wide field Fluorescein Angiography on the Diagnosis and Management of Diabetic RetinopathyNicole K Scripsema, Tala Al-Khaled, Amy Song, et al.
Retina (Philadelphia, Pa.)|April 13, 2004
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4Mohammad Azab, Mustapha Benchaboune, Kevin J Blinder, et al.
Ophthalmology|April 12, 2003
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3Kevin J Blinder, Mark S Blumenkranz, Neil M Bressler, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
Pageof 44

Showing results (411-420 of 432) with videos related to

Sort By:
Pageof 44
Epigenetics|September 12, 2012
Measuring the methylome in clinical samples: improved processing of the Infinium Human Methylation450 BeadChip ArrayHong Pan, Li Chen, Shaillay Dogra, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
The Veterinary Record|January 8, 2008
Feed contaminated with classical swine fever vaccine virus (LOM strain) can induce antibodies to the virus in pigsB Kim, J-Y Song, D-S Tark, et al.
Ophthalmology|February 21, 2024
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Arshad M Khanani, Aachal Kotecha, Andrew Chang, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
Signal Transduction and Targeted Therapy|October 21, 2025
Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunctionMaximilian A McCann, Basma Baccouche, Yueru Li, et al.
Journal of Vitreoretinal Diseases|August 5, 2025
The Influence of Ultra-Wide field Fluorescein Angiography on the Diagnosis and Management of Diabetic RetinopathyNicole K Scripsema, Tala Al-Khaled, Amy Song, et al.
Retina (Philadelphia, Pa.)|April 13, 2004
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4Mohammad Azab, Mustapha Benchaboune, Kevin J Blinder, et al.
Ophthalmology|April 12, 2003
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3Kevin J Blinder, Mark S Blumenkranz, Neil M Bressler, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
Pageof 44